A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic modelCraig H. Moskowitz, Joachim Yahalom, Stephen D. Nimer et al.|Blood|2001Cited by 427
Value of Histopathology in Predicting Microsatellite Instability in Hereditary Nonpolyposis Colorectal Cancer and Sporadic Colorectal CancerJinru Shia, David S. Klimstra, Nathan A. Ellis et al.|The American Journal of Surgical Pathology|2003Cited by 227
Treatment Strategies for Deficiency of Adenosine Deaminase 2Amanda K. Ombrello, Daniel L. Kastner, Jing Qin et al.|New England Journal of Medicine|2019Cited by 195
Patterns of Morphologic Alteration in Residual Rectal Carcinoma Following Preoperative Chemoradiation and Their Association With Long-term OutcomeJinru Shia, David S. Klimstra, José G. Guillem et al.|The American Journal of Surgical Pathology|2004Cited by 194
Intensive chemotherapy with cyclophosphamide, doxorubicin, high‐dose methotrexate/ifosfamide, etoposide, and high‐dose cytarabine (CODOX‐M/IVAC) for human immunodeficiency virus–associated Burkitt lymphomaEunice S. Wang, Ariela Noy, David J. Straus et al.|Cancer|2003Cited by 151